» Articles » PMID: 36950232

Dysplasia and Tumor Discrimination in Brain Tissues by Combined Fluorescence, Raman, and Diffuse Reflectance Spectroscopies

Overview
Specialty Radiology
Date 2023 Mar 23
PMID 36950232
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of neoplastic and dysplastic brain tissues is of paramount importance for improving the outcomes of neurosurgical procedures. This study explores the combined application of fluorescence, Raman and diffuse reflectance spectroscopies for the detection and classification of brain tumor and cortical dysplasia with a label-free modality. Multivariate analysis was performed to evaluate classification accuracies of these techniques-employed both in individual and multimodal configuration-obtaining high sensitivity and specificity. In particular, the proposed multimodal approach allowed discriminating tumor/dysplastic tissues against control tissue with 91%/86% sensitivity and 100%/100% specificity, respectively, whereas tumor from dysplastic tissues were discriminated with 89% sensitivity and 86% specificity. Hence, multimodal optical spectroscopy allows reliably differentiating these pathologies using a non-invasive, label-free approach that is faster than the gold standard technique and does not require any tissue processing, offering the potential for the clinical translation of the technology.

Citing Articles

Optical Methods for Brain Tumor Detection: A Systematic Review.

Burstrom G, Amini M, El-Hajj V, Arfan A, Gharios M, Buwaider A J Clin Med. 2024; 13(9).

PMID: 38731204 PMC: 11084501. DOI: 10.3390/jcm13092676.


Introduction to the Optics and the Brain 2023 feature issue.

Bauer A, Gibson E, Wang H, Srinivasan V Biomed Opt Express. 2024; 15(4):2110-2113.

PMID: 38633102 PMC: 11019680. DOI: 10.1364/BOE.517678.


Optical Differentiation of Brain Tumors Based on Raman Spectroscopy and Cluster Analysis Methods.

Ospanov A, Romanishkin I, Savelieva T, Kosyrkova A, Shugai S, Goryaynov S Int J Mol Sci. 2023; 24(19).

PMID: 37833879 PMC: 10573074. DOI: 10.3390/ijms241914432.

References
1.
Yamaguchi F . The Border Zone of Tumor. Where is the Border? What is a Surgical Border for Patients?. World Neurosurg X. 2019; 2:100011. PMC: 6580876. DOI: 10.1016/j.wnsx.2019.100011. View

2.
Nazeer S, Saraswathy A, Gupta A, Jayasree R . Fluorescence spectroscopy as a highly potential single-entity tool to identify chromophores and fluorophores: study on neoplastic human brain lesions. J Biomed Opt. 2013; 18(6):067002. DOI: 10.1117/1.JBO.18.6.067002. View

3.
Zhang J, Fan Y, He M, Ma X, Song Y, Liu M . Accuracy of Raman spectroscopy in differentiating brain tumor from normal brain tissue. Oncotarget. 2017; 8(22):36824-36831. PMC: 5482701. DOI: 10.18632/oncotarget.15975. View

4.
Baria E, Cicchi R, Malentacchi F, Mancini I, Pinzani P, Pazzagli M . Supervised learning methods for the recognition of melanoma cell lines through the analysis of their Raman spectra. J Biophotonics. 2020; 14(3):e202000365. DOI: 10.1002/jbio.202000365. View

5.
Gebhart S, Lin W, Mahadevan-Jansen A . In vitro determination of normal and neoplastic human brain tissue optical properties using inverse adding-doubling. Phys Med Biol. 2006; 51(8):2011-27. DOI: 10.1088/0031-9155/51/8/004. View